Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
| Ethyl 5-[(2S,3S,4R)-3,4-dihydroxypyrrolidin-2-yl]-2-methyl-3-furoate | IC50 | 12000.0 [1] | |
| Ethyl 5-[(2S,3S,4R)-3,4-dihydroxypyrrolidin-2-yl]-2-methyl-3-furoate | Ki | 6400.0 [1], 6600.0 [2] | |
| (1s,2s,3s,6r)-4-(Hydroxymethyl)-6-(Octylamino)cyclohex-4-Ene-1,2,3-Triol | IC50 | 125.0 [1] | |
| (1s,2s,3s,6r)-4-(Hydroxymethyl)-6-(Octylamino)cyclohex-4-Ene-1,2,3-Triol | Ki | 300.0 [1], 510.0 [2] | |
| (3R,4S,5R,6R)-5-(Hydroxymethyl)-6-pentylpiperidine-3,4-diol | IC50 | 8.0 [1], 10.0 [2], 180.0 [3] | |
MLA | "Quest Database™ Beta-galactosidase Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 28 Dec. 2025, https://www.aatbio.com/data-sets/beta-galactosidase-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2025, December 28). Quest Database™ Beta-galactosidase Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/beta-galactosidase-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |